TUMS Launches Limited-Edition Burn Ball Football for Game Day Heartburn Relief
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: PRnewswire
- Brand Collaboration: TUMS partners with viral creator Airrack for a playful marketing campaign featuring trick shots and social sweepstakes, aimed at engaging younger audiences and enhancing brand visibility.
- Market Demand: Research indicates that one in four Super Bowl viewers experience occasional heartburn while enjoying their favorite foods, with 75% unprepared for relief, highlighting a significant market need for quick and effective heartburn solutions.
- Product Innovation: The Burn Ball football is not only a limited-edition item but also specifically designed to pass TUMS, providing consumers with a fast-acting heartburn relief solution on game day, thereby enhancing the brand's competitive edge in the market.
- Marketing Strategy: By integrating sports and entertainment elements, TUMS's innovative product is expected to attract more young consumers, boost brand loyalty, and drive sales growth, particularly during the critical Super Bowl marketing window.
Analyst Views on HLN
Wall Street analysts forecast HLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLN is 13.44 USD with a low forecast of 13.44 USD and a high forecast of 13.44 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 10.270
Low
13.44
Averages
13.44
High
13.44
Current: 10.270
Low
13.44
Averages
13.44
High
13.44
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
